- Home
- EBON vs ABP Comparison
EBON vs ABP Comparison
Compare EBON & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBON | ABP |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 18.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBON | ABP |
|---|---|---|
| Price | $3.89 | $5.78 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.9K | ★ 28.9K |
| Earning Date | 08-15-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,337,066.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 104.28 | 50.00 |
| 52 Week Low | $3.00 | $4.55 |
| 52 Week High | $8.54 | $153.90 |
Technical Indicators
Market Signals| Indicator | EBON | ABP |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 57.16 |
| Support Level | $3.37 | $5.41 |
| Resistance Level | $3.89 | $6.19 |
| Average True Range (ATR) | 0.18 | 0.58 |
| MACD | 0.04 | -0.26 |
| Stochastic Oscillator | 26.92 | 32.10 |
Price Performance
Historical ComparisonAbout EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About ABP Abpro Holdings Inc
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.